[1] WARDLAW J M，SMITH E E，BIESSELS G J，et

al. Neuroimaging standards for research into small

vessel disease and its contribution to ageing and

neurodegeneration[J]. Lancet Neurol，2013，12（8）：

822-838.

[2] WERRING D J. Cerebral microbleeds：clinical and

pathophysiological significance[J]. J Neuroimaging，

2007，17（3）：193-203.

[3] POELS M M，IKRAM M A，VAN DER LUGT A，et

al. Incidence of cerebral microbleeds in the general

population：the Rotterdam Scan Study[J]. Stroke，2011，

42（3）：656-661.

[4] ROMERO J R，PREIS S R，BEISER A，et al. Risk

factors，stroke prevention treatments，and prevalence

of cerebral microbleeds in the Framingham Heart

Study[J]. Stroke，2014，45（5）：1492-1494.

[5] KOENNECKE H C. Cerebral microbleeds on MRI：

prevalence，associations，and potential clinical

implications[J]. Neurology，2006，66（2）：165-171.

[6] CORDONNIER C，AL-SHAHI SALMAN

R，WARDLAW J. Spontaneous brain microbleeds：

systematic review，subgroup analyses and standards

for study design and reporting[J]. Brain，2007，130（Pt

8）：1988-2003.

[7] SVEINBJORNSDOTTIR S，SIGURDSSON S，

ASPELUND T，et al. Cerebral microbleeds in the

population based AGES-Reykjavik study：prevalence

and location[J]. J Neurol Neurosurg Psychiatry，2008，

79（9）：1002-1006.

[8] FAZEKAS F，KLEINERT R，ROOB G，et al.

Histopathologic analysis of foci of signal loss on

gradient-echo T2

*-weighted MR images in patients with

spontaneous intracerebral hemorrhage：evidence of

microangiopathy-related microbleeds[J]. AJNR Am J

Neuroradiol，1999，20（4）：637-642.

[9] PASI M，BOULOUIS G，FOTIADIS P，et al.

Distribution of lacunes in cerebral amyloid angiopathy

and hypertensive small vessel disease[J]. Neurology，

2017，88（23）：2162-2168.

[10] VERNOOIJ M W，VAN DER LUGT A，IKRAM M A，

et al. Prevalence and risk factors of cerebral microbleeds：

in the Rotterdam Scan Study[J]. Neurology，2008，70

（14）：1208-1214.

[11] KIM B J，LEE S H. Cerebral microbleeds：their

associated factors，radiologic findings，and clinical

implications[J]. J Stroke，2013，15（3）：153-163.

[12] RYU W S，LEE S H，KIM C K，et al. The relation

between chronic kidney disease and cerebral

microbleeds：difference between patients with and

without diabetes[J]. Int J Stroke，2012，7（7）：551-557.

[13] SHIMA H，ISHIMURA E，NAGANUMA T，et

al. Cerebral microbleeds in predialysis patients with

chronic kidney disease[J]. Nephrol Dial Transplant，

2010，25（5）：1554-1559.

[14] MESKER D J，POELS M M，IKRAM M A，et al. Lobar

distribution of cerebral microbleeds：the Rotterdam Scan

Study[J]. Arch Neurol，2011，68（5）：656-659.

[15] GREENBERG S M，VERNOOIJ M W，CORDONNIER

C，et al. Cerebral microbleeds：a guide to detection and

interpretation[J]. Lancet Neurol，2009，8（2）：165-174.

[16] CHARIDIMOU A，JÄGER H R，WERRING D J.

Cerebral microbleed detection and mapping：principles，

methodological aspects and rationale in vascular

dementia[J]. Exp Gerontol，2012，47（11）：843-852.

[17] NANDIGAM R N，VISWANATHAN A，DELGADO

P，et al. MR imaging detection of cerebral microbleeds：

effect of susceptibility-weighted imaging，section

thickness，and field strength[J]. AJNR Am J

Neuroradiol，2009，30（2）：338-343.

[18] AYAZ M，BOIKOV A S，HAACKE E M，et al. Imaging

cerebral microbleeds using susceptibility weighted

imaging：one step toward detecting vascular dementia[J].

J Magn Reson Imaging，2010，31（1）：142-148.

[19] AKTER M，HIRAI T，HIAI Y，et al. Detection

of Hemorrhagic hypointense foci in the brain on

susceptibility-weighted imaging clinical and phantom

studies[J]. Acad Radiol，2007，14（9）：1011-1019.

[20] HAACKE E M，AYAZ M，KHAN A，et al.

Establishing a baseline phase behavior in magnetic

resonance imaging to determine normal vs. abnormal

iron content in the brain[J]. J Magn Reson Imaging，

2007，26（2）：256-264.

[21] GUO L F，WANG G，ZHU X Y，et al. Comparison

of ESWAN，SWI-SPGR，and 2D T2

*-weighted GRE

sequence for depicting cerebral microbleeds[J]. Clin

Neuroradiol，2013，23（2）：121-127.

[22] CHENG A L，BATOOL S，MCCREARY C R，et al.

Susceptibility-weighted imaging is more reliable than

T2

*-weighted gradient-recalled echo MRI for detecting

microbleeds[J]. Stroke，2013，44（10）：2782-2786.

[23] HAUTVAST G L，CHIRIBIRI A，LOCKIE T，et

al. Quantitative analysis of transmural gradients in

myocardial perfusion magnetic resonance images[J].

Magn Reson Med，2011，66（5）：1477-1487.

[24] HAUSSEN D C，HENNINGER N，KUMAR S，et al.

Statin use and microbleeds in patients with spontaneous

intracerebral hemorrhage[J]. Stroke，2012，43（10）：

2677-2681.

[25] SOO Y O，YANG S R，LAM W W，et al. Risk vs

benefit of anti-thrombotic therapy in ischaemic stroke

patients with cerebral microbleeds[J]. J Neurol，2008，

255（11）：1679-1686.

[26] VERNOOIJ M W，HAAG M D，VAN DER LUGT A，

et al. Use of antithrombotic drugs and the presence of

cerebral microbleeds：the Rotterdam Scan Study[J].

Arch Neurol，2009，66（6）：714-720.

[27] DARWEESH S K，LEENING M J，AKOUDAD S，et

al. Clopidogrel use is associated with an increased

prevalence of cerebral microbleeds in a stroke-free

population：the Rotterdam study[J]. J Am Heart Assoc，

2013，2（5）：e000359.

[28] VISWANATHAN A，CHABRIAT H. Cerebral

microhemorrhage[J]. Stroke，2006，37（2）：550-555.

[29] YAMASHIRO K，TANAKA R，OKUMA Y，et

al. Associations of durations of antiplatelet use and

vascular risk factors with the presence of cerebral

microbleeds[J]. J Stroke Cerebrovasc Dis，2014，23（3）：

433-440.

[30] LOVELOCK C E，CORDONNIER C，NAKA H，et

al. Antithrombotic drug use，cerebral microbleeds，

and intracerebral hemorrhage：a systematic review of

published and unpublished studies[J]. Stroke，2010，41

（6）：1222-1228.

[31] BATH P M，WARDLAW J M. Pharmacological

treatment and prevention of cerebral small vessel

disease：a review of potential interventions[J]. Int J

Stroke，2015，10（4）：469-478.